Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone
Clinical trial NCT02027961 · COMPLETED
Trial details
- NCT number
- NCT02027961
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-20
- Primary completion
- 2018-04-24
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.